Clinical Trial Update: Urokinase Therapy in Diabetic Foot Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of urokinase therapy for diabetic foot syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Disease
• Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Urokinase (urokinase)

Snippet

Sponsor: medac GmbH | Conditions: Diabetic Foot, Arterial Occlusive Disease | Phase 2 | Status: COMPLETED